Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones.

DE Anderson, LJ Ausubel, J Krieger… - … (Baltimore, Md.: 1950 …, 1997 - journals.aai.org
DE Anderson, LJ Ausubel, J Krieger, P Höllsberg, GJ Freeman, DA Hafler
Journal of immunology (Baltimore, Md.: 1950), 1997journals.aai.org
The influence of costimulation on the T cell response to altered peptide ligands that act as
either partial or weak agonists for human CD4+ T cell clones was examined. Using stable
Chinese hamster ovary (CHO) cell transfectants expressing DR2 (DRB1* 1501) and human
B7-1 or B7-2 as APC, presentation of native myelin basic protein (MBP) p85-99 peptide Ag
or a partial agonist of MBP p85-99 induced equivalent T cell activation as measured by [3H]
TdR incorporation and cytokine secretion. In marked contrast, presentation of cross-reactive …
Abstract
The influence of costimulation on the T cell response to altered peptide ligands that act as either partial or weak agonists for human CD4+ T cell clones was examined. Using stable Chinese hamster ovary (CHO) cell transfectants expressing DR2 (DRB1*1501) and human B7-1 or B7-2 as APC, presentation of native myelin basic protein (MBP) p85-99 peptide Ag or a partial agonist of MBP p85-99 induced equivalent T cell activation as measured by [3H]TdR incorporation and cytokine secretion. In marked contrast, presentation of cross-reactive peptides of MBP p85-99 that act as weak agonists with B7-1, but not B7-2, costimulation resulted in significant T cell activation as measured by [3H]TdR incorporation and cytokine secretion. These data suggest that decreasing the strength of the signal provided to the TCR allows differences in B7-1 and B7-2 signaling to be observed. Thus, the costimulatory environment during T cell activation may be a mechanism of regulating T cell cross-reactivity in the periphery.
journals.aai.org